2 unknown, 1 completed, 1 terminated. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 2, Completed 1, Terminated 1 |
Follow Relapsed or Refractory Acute Lymphoblastic Leukemia: new trials by email Literature Review of Relapsed or Refractory Acute Lymphoblastic Leukemia trials Research Report on Relapsed or Refractory Acute Lymphoblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia ssCART-19 Cells, Fludarabine, Cyclophosphamide - Relapsed or Refractory Acute Lymphoblastic Leukemia | Phase 1 | Unknown | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 18 | 2021-04-09 | 2023-09-21 |
| A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia single dose of CNCT19 - Relapsed or Refractory Acute Lymphoblastic Leukemia | Phase 1 | Completed | Juventas Cell Therapy Ltd. | 10 | 2020-03-13 | 2023-03-28 |
| A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL C-CAR-011 - Relapsed or Refractory Acute Lymphoblastic Leukemia | Phase 1 | Unknown | Shanghai AbelZeta Ltd. | 20 | 2017-01-01 | 2017-01-20 |
| Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia MLN9708, Vincristine, Doxorubicin - Relapsed or Refractory Acute Lymphoblastic Leukemia, Relapsed or Refractory Lymphoblastic Lymphoma | Phase 1 | Terminated | Ehab L Atallah | 5 | 2013-06-01 | 2020-01-22 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Recurrence (4) · Leukemia, Biphenotypic, Acute (1)
Disease Attributes (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Leukemia (4) · Leukemia, Lymphoid (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4)
Calcium Dobesilate (1) · Cyclophosphamide (1) · Dexamethasone (1) · Doxorubicin (1) · Vincristine (1) · fludarabine (1) · ixazomib (1) · liposomal doxorubicin (1)
Ehab L Atallah (1) · Juventas Cell Therapy Ltd. (1) · Shanghai AbelZeta Ltd. (1) · Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd (1)
China (3) · United States (1)
Ehab L Atallah, MD (1) · Jianxiang Wang, Dr. (1) · Li Yu (1)